Rein Therapeutics

Contributing Author

Recent Articles by Rein Therapeutics

Nov-06	Rein Therapeutics Announces New Scientific Publication Demonstrating LTI-03 May Reduce Lung Scarring and Protect Cells Needed for Lung Repair in IPF RNTX GlobeNewswire
Nov-03	Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis RNTX GlobeNewswire
Oct-09	Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis RNTX GlobeNewswire
Sep-17	Rein Therapeutics Announces Publication of New Translational Data in iScience on Company's Novel Therapy for Idiopathic Pulmonary Fibrosis RNTX GlobeNewswire
Aug-19	Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis RNTX GlobeNewswire
Aug-14	Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025 RNTX GlobeNewswire
Jul-30	Rein Therapeutics Enters into Agreements for up to $21 Million in Flexible Financing RNTX GlobeNewswire